Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. - Wikidata - wikimedia - TriplyDB

Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.

Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.

http://www.wikidata.org/entity/Q33744178

about

Multiple myeloma in the older adult: better prospects, more challenges.Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis Patient, Physician and Contextual Factors Are Influential in the Treatment Decision Making of Older Adults Newly Diagnosed with Symptomatic Myeloma.Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: a systematic review and meta-analysis.Second malignancies after multiple myeloma: from 1960s to 2010s.Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.Managing multiple myeloma in the elderly: are we making progress?Efficacy and safety of busulfan-based conditioning regimens for multiple myeloma Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.International Staging System predicts prognosis of Chinese patients with multiple myeloma across different calendar periods with application of novel agents.Novel investigational drugs active as single agents in multiple myeloma.The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.Management of Elderly Patients with Plasma Cell Myeloma.Aging: Treating the Older Patient.Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns.Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy.Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.Clinical features and treatment outcome of very elderly patients over 80 years old with multiple myeloma: comparison with patients in different age groups in the era of novel agents.Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999-2010: comparison to plasma cell myeloma.Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?Clinical risk factors of Plasmacytoma mortality: a US population-based study.Cancer incidence in Canada: trends and projections (1983–2032).Outcome and survival of myeloma patients diagnosed 2008-2015. Real world data on 4904 patients from the Swedish Myeloma Registry (SMR).Pre-existing diabetes mellitus in patients with multiple myeloma.Treat or palliate: outcomes of very elderly myeloma patients.Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project.Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.Real life management of patients hospitalized with multiple myeloma in France.Multiple myeloma A Case of Multiple Myeloma Associated with Extramedullary Plasmacytoma of the Gallbladder Manifesting as Acute Cholecystitis

P2860

Q34031129-11502D6F-750B-4BA3-A704-4266498D8D06 Q34411693-079B5E4A-14C7-410E-8063-18D09945D98C Q34781514-B7411453-8E16-463D-8F99-3864F079143E Q35104606-25C044E2-C6E9-4524-A12C-6CFCC91826C5 Q35891594-035C21C6-7B9F-4411-829C-089B6E1549EB Q36115615-4B9ED8D2-FCBE-4454-BD8E-653E51F1A69B Q36526751-C90EA000-BEDF-407F-A72A-3A680E7D65A4 Q37580855-C2A74DDC-C93D-4AE4-A085-30BA1B09D6DC Q37664019-26BAFB4B-A3AA-4C9C-85A7-8A78654854DC Q37888716-3235BE95-ED67-410D-93E5-0C43A8CC6391 Q38102892-FF7C2FEB-78F1-4179-9E94-5CC0949FB58A Q38367654-1DFD1388-94B1-41AB-807D-B099826D946F Q38438670-7BD517F8-26C2-4F88-8482-066399F7DD89 Q38690290-C7ED4C5E-F925-49AE-8E7F-2B133447EABB Q38714291-A16B6271-BD5C-40D3-B5F7-63C068C4218B Q38789129-498FD3CA-F7E9-4631-BD9B-00BAB0ACF5C2 Q39001325-F24A0AA8-BD97-429A-85CC-3BBE8094E9A2 Q39013605-576AED29-C86C-46D5-83EB-64DE25D47AE7 Q39640777-04695439-E835-415A-9968-DC71AD110E23 Q40098572-00510C4A-E9CD-4B03-915A-BD7635FC6414 Q40150284-5A048AD4-D50C-409D-8744-71BF4A69F779 Q40561960-8A4C403F-0A2C-4DCF-BD99-0B5DA9257FA8 Q41605875-3E87A7F0-EC84-4866-A7D8-E6683B605322 Q41622165-B5A6BDF2-367C-4036-8B00-2D5757E3E3BC Q42373431-9125C7D3-97A8-4A4C-9CF2-8C8E38FB3651 Q43087338-1D8CEB9F-A922-425F-AF0C-3A12ADF253D4 Q44156581-26537CD7-F363-4711-9E06-721DB1097EC6 Q44956731-68452039-8E61-4CF5-AD74-D56FD63C1D67 Q45266225-9D734F84-3965-46E1-A4A4-DFBE84D4A02C Q46495297-59C02AEA-DC74-4B76-857D-81D43F3FC608 Q47198067-41A9594F-FBEA-42DD-A22A-D7C225E8006D Q48651168-C16F8ED4-A89E-40F3-AABF-0B30059DB28F Q49868035-7089C472-7E87-4093-8486-E5221C21C5A3 Q50145894-53811B86-3CAD-4FA1-8F95-B8023659E655 Q53811677-9E650E7F-0174-4C21-8B39-74A88C4DC1F4 Q54941675-062FD284-CE1E-45CF-A023-F4E2919BA4A8 Q56657250-B2FB8EE1-37CC-4936-9501-E05A58F70806 Q57652872-7F0F45CC-B8B3-475C-8C84-73393A25EBDC

P2860

Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.

http://www.wikidata.org/entity/Q33744178

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Patterns of multiple myeloma d ...... ge distribution in the clinic.

@ast

Patterns of multiple myeloma d ...... ge distribution in the clinic.

@en

type

label

Patterns of multiple myeloma d ...... ge distribution in the clinic.

@ast

Patterns of multiple myeloma d ...... ge distribution in the clinic.

@en

prefLabel

Patterns of multiple myeloma d ...... ge distribution in the clinic.

@ast

Patterns of multiple myeloma d ...... ge distribution in the clinic.

@en

P1433

Q33744178-299C9E58-499C-4FAC-9146-DAFA6D3065C3

P1476

Q33744178-F2149464-490E-4822-A5C3-C3D48F0CB61A

P2093

Q33744178-33DF6B77-12E3-4DAC-AE2E-FEFFB65B96B7

Q33744178-529DAA8F-CC77-4E22-9DBB-B3E77A723E4B

Q33744178-6A7DC101-AA92-42FE-86D9-D9E221007232

P2860

Q33744178-0A83FBF4-3DA3-4B4A-AC0D-7397F37F2E20

Q33744178-0D561F17-CA38-44A1-8630-9D2D2AC8FDA4

Q33744178-1029E3B3-03FE-47CA-91FC-34939EB22008

Q33744178-14C010C0-AFA9-4D1F-A392-5FD54434C51C

Q33744178-172578AC-7A14-4C4A-B9EA-B07A467E75EB

Q33744178-24CE698A-F247-4337-B49A-046AFEAA0B6B

Q33744178-3EA1B9B1-07DD-4B3C-B0D4-5995C2917DDD

Q33744178-5006ADAD-CA60-4B6E-A34A-B22E1A94FB28

Q33744178-60D2409B-5203-4DE5-836D-F210D7BDBBE6

Q33744178-69202889-622C-4B7C-B77D-4E65F44B4B1A

P304

Q33744178-812C0F1F-B366-48B5-9579-260DE7C9F4B2

P31

Q33744178-E77122C8-9D4E-49B9-9861-5BAD48A7D5B8

P356

Q33744178-1289EB2C-8D28-49E1-8B96-B5B56142711F

P407

Q33744178-C01BDCE6-8509-4226-97C6-CCC32F9ABB18

P433

Q33744178-2C6D5CB2-6607-42F7-AF62-FD0722B7F478

P478

Q33744178-657DB646-AA9E-4403-874A-0DE0826223C0

P50

Q33744178-9EEBCB8D-7142-4779-A042-D5F9994C8610

P577

Q33744178-115BBE1E-5E94-43D9-88B9-BEE931ACB794

P5875

Q33744178-9279F9EE-9460-4339-8929-47AF88C8B2F2

P698

Q33744178-DE3A4318-F714-43E9-87D3-AB6AD01475C2

P932

Q33744178-701D85A3-A028-4318-BA20-F2691F52E38E

P356

P1433

Mayo Clinic Proceedings

P1476

Patterns of multiple myeloma d ...... ge distribution in the clinic.

@en

P2093

Ingemar Turesson

http://www.w3.org/2001/XMLSchema#string

Ramon Velez

http://www.w3.org/2001/XMLSchema#string

Sigurdur Y Kristinsson

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2000.

Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades.

Familial risks and temporal incidence trends of multiple myeloma.

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.

Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis.

Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.

Multiple myeloma in the United States, 1950--1975.

Cancer incidence and mortality trends among whites in the United States, 1947-84.

A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.

P304

225-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4065/MCP.2009.0426

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41656280

http://www.w3.org/2001/XMLSchema#string

P698

20194150

http://www.w3.org/2001/XMLSchema#string

P932

2843108

http://www.w3.org/2001/XMLSchema#string